Journal of Cachexia, Sarcopenia and Muscle Q1 Unclaimed
Journal of Cachexia, Sarcopenia and Muscle is a journal indexed in SJR in Physiology (medical) and Orthopedics and Sports Medicine with an H index of 100. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 2250 €. The scope of the journal is focused on cachexia, sarcopenia, muscle, muscle wasting, wasting syndromes, body composition. It has an SJR impact factor of 2,816 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,816.
Type: Journal
Type of Copyright: CC BY-NC-ND
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
2250 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
2,816
SJR Impact factor100
H Index251
Total Docs (Last Year)592
Total Docs (3 years)10280
Total Refs5523
Total Cites (3 years)530
Citable Docs (3 years)9.34
Cites/Doc (2 years)40.96
Ref/DocOther journals with similar parameters
Circulation Q1
Nature Metabolism Q1
Sleep Medicine Reviews Q1
Circulation: Arrhythmia and Electrophysiology Q1
JACC: Clinical Electrophysiology Q1
Compare this journals
Aims and Scope
Best articles by citations
A systematic review on the role of vitamins, minerals, proteins, and other supplements for the treatment of cachexia in cancer: a European Palliative Care Research Centre cachexia project
View moreMuscle mass measures and incident osteoporosis in a large cohort of postmenopausal women
View morePreoperative sarcopenia and post-operative accelerated muscle loss negatively impact survival after resection of pancreatic cancer
View morePsoas
View morePoor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis
View morePsoas muscle fluorine-18-labelled fluoro-2-deoxy-d-glucose uptake associated with the incidence of existing and incipient metabolic derangement
View morePrevalence of sarcopenia among community-dwelling elderly of a medium-sized South American city: results of theCOMO VAI? study
View moreAssessing sarcopenic prevalence and risk factors in residential aged care: methodology and feasibility
View moreIncreased desmin expression in hindlimb muscles of aging rats
View moreMuscle radiodensity loss during cancer therapy is predictive for poor survival in advanced endometrial cancer
View moreBreakthrough in cachexia treatment through a novel selective androgen receptor modulator?!
View moreTargeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia
View moreSilver linings on the horizon: highlights from the 10th Cachexia Conference
View moreExercise restores muscle stem cell mobilization, regenerative capacity and muscle metabolic alterations via adiponectin/AdipoR1 activation in SAMP10 mice
View moreComputed tomography diagnosed cachexia and sarcopenia in 725 oncology patients: is nutritional screening capturing hidden malnutrition?
View moreSirtuin 1 in skeletal muscle of cachectic tumour-bearing rats: a role in impaired regeneration?
View moreTrimetazidine restores the positive adaptation to exercise training by mitigating statin-induced skeletal muscle injury
View moreSources for skeletal muscle repair: from satellite cells to reprogramming
View moreFebuxostat improves outcome in a rat model of cancer cachexia
View moreThe orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia
View moreErratum to: Assessing sarcopenic prevalence and risk factors in residential aged care: methodology and feasibility
View moreGrowth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia
View moreDegenerin channel activation causes caspase-mediated protein degradation and mitochondrial dysfunction in adultC.elegansmuscle
View moreTumour-specific and organ-specific protein synthesis rates in patients with pancreatic cancer
View more
Comments